Spine Surgery | Researchers at the Mayo Clinic hope that a Phase I clinical trial will enable them to guide newly grown stem cells to become protective of neuromuscular function and that it will shed light on ways to halt or slow the progression of amyotrophic lateral sclerosis.
“We use fat-derived mesenchymal stem cells from the patient’s own body.
No comment yet.
Sign up to comment